HONG KONG, Dec. 11, 2025 -- ATFX, a globally regulated fintech broker specialising in FX and CFDs, is proud to announce a strategic data infrastructure collaboration with KX, a leading software company specialising in time-series data management and analytics. This collaboration aims to enhance ATFX's technology platform with faster analytics, smarter automation, and greater operational efficiency, delivering more timely insights and better decision-making across its trading operations. These operations involve managing complex data flows from numerous liquidity providers and prime brokers, s
XIAMEN, China, Dec. 11, 2025 -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today announced the change of its name to "High Templar Tech Limited" and its ticker symbol to "HTT". As previously announced by the Company on November 12, 2025, its board of directors (the "Board") resolved to (i) change the Company's name to "High Templar Tech Limited" (the "Name Change"), subject to shareholders' approval to be obtained at an extraordinary general
BEIJING, Dec. 11, 2025 -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading Fintech company specializing in digital consumer lending, insurance and financial technology innovation across China and Southeast Asia, today announced it has been awarded the "Technology Innovation Leadership Award for Listed Companies" at the 23rd China's Financial Annual Champion Awards. The award was presented during the 2025 China Financial Annual Conference, held in Beijing and co-hosted by the China Stock Exchange Executive Council and the leading financ
[ 메디채널 김장윤(JASON KIM) 기자 ] Showcasing the full spectrum of American Whiskey and setting the high benchmark for Taipei's one-of-a-kind Outdoor Whiskey Festival TAIPEI, Dec. 11, 2025 -- The second annual Taiwan American Whiskey & Bourbon Festival successfully wrapped up on December 7 at Xinyi Xiangti Avenue in Taipei. Blessed with three days of clear weather, the event attracted over 1,800 whiskey enthusiasts, media, and international guests, transforming Taipei 101 precinct into a vibrant, celebrative, all-American carnival over the weekend. Organized by Joie de Viv
Landmark year marked by successful listings across Singapore, Malaysia, and Thailand, spanning Singapore Exchange ("SGX") Mainboard, Catalist, Bursa Malaysia Main Market, and the Stock Exchange of Thailand ("SET"). Key milestones include Info-Tech Systems' Mainboard IPO, China Medical System's secondary listing, and Lum Chang Creations' Catalist debut in Singapore; UMS Integration's secondary listing, and Paradigm REIT's Main Market IPO in Malaysia; Mr D.I.Y. Thailand's listing on the SET. Out of 63 deals completed up to 11 December 2025, 14 were IPOs listed
HONG KONG, Dec. 11, 2025 -- Bowtie, Hong Kong's first virtual insurer[1], announces the strategic relocation of its headquarters to 68 Johnston Road, Wan Chai. Effective 1 February 2026, the building will be officially renamed "Bowtie Life Insurance Tower" ("Bowtie Tower"). Located in a prime and highly visible district, this milestone marks Bowtie's growth from a home-grown startup into Hong Kong's leading digital insurer, reaffirming its long-term commitment to the city. To support its continuous business growth, Bowtie has signed a five‑year lease spanning seven
[ 메디채널 김갑성 기자 ] Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, including those who have relapsed or are refractory to checkpoint inhibitors, a multi-billion dollar pillar of cancer care, hampered by widespread resistance The study achieved its objective, as the new Q6W extended dosing interval produced encouraging anti-tumor efficacy and immunological data in prior immune-oncology refractory or relapsed patients including anti-PD- (L)1 checkpoint inhibitor, with improved safety, compared to the prior Q2W schedule Th
[ 메디채널 김갑성 기자 ] Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and strong drug discovery capabilities, to discover and develop novel therapeutics for multiple targets in metabolic diseases OTR Therapeutics will receive an initial upfront payment of USD 20 million, which may increase to USD 30 million under certain pre-agreed conditions, and is eligible for potential preclinical, development, regulatory, and commercial milestone payments, for a potential total consideration of up to USD ~2
TAIPEI, Dec. 11, 2025 -- Taiwan boasts an extensive island-circling cycling route network and a diverse landscape spanning cities, mountains, and coastlines, offering riders a wide range of cycling environments. Visitors can travel at a relaxed pace between urban areas and the mountains and sea, while also enjoying local culture, cuisine, and natural scenery. This makes Taiwan an ideal destination for cycling enthusiasts around the world who want a deeper travel experience. The Taiwan Tourism Administration (TTA) has long been committed to improving the cycling tourism environment. In additio
HONG KONG and LONDON, Dec. 11, 2025 -- CONDUCA Consulting ("CONDUCA") and PayTech Consulting ("PayTech") are pleased to announce a strategic partnership that brings together their complementary expertise in travel management, payments and financing advisory services, analytics and enterprise performance solutions. This collaboration will enable both firms to complement their respective areas of expertise and to deliver enhanced service offerings and integrated, high-impact solutions for their mutual client bases. CONDUCA helps organisations optimise travel programme